Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CALA

Calithera Biosciences

$14.20

-0.85 (-5.65%)

07:14
06/12/17
06/12
07:14
06/12/17
07:14
Recommendations
Calithera Biosciences analyst commentary at H.C. Wainwright »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$45.48

-0.505 (-1.10%)

, PEP

PepsiCo

$116.85

-0.855 (-0.73%)

16:12
06/07/17
06/07
16:12
06/07/17
16:12
General news
On The Fly: Top stock stories for Wednesday »

Stocks opened in positive…

KO

Coca-Cola

$45.48

-0.505 (-1.10%)

PEP

PepsiCo

$116.85

-0.855 (-0.73%)

DPS

Dr Pepper Snapple

$93.39

1.095 (1.19%)

SAN

Banco Santander

$6.52

0.155 (2.44%)

BPESY

Banco Popular

$0.05

-1.565 (-97.21%)

KITE

Kite Pharma

$82.10

5.46 (7.12%)

NVS

Novartis

$81.21

-0.63 (-0.77%)

BLUE

bluebird bio

$109.15

10.95 (11.15%)

PLAY

Dave & Buster's

$72.89

2.72 (3.88%)

CALA

Calithera Biosciences

$16.30

0.9 (5.84%)

DLTH

Duluth Holdings

$16.75

-3.82 (-18.57%)

AMBA

Ambarella

$53.60

-6.12 (-10.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 07

    Jun

  • 07

    Jun

  • 08

    Jun

  • 13

    Jun

  • 13

    Jun

  • 13

    Jun

  • 20

    Jun

  • 20

    Jun

  • 22

    Jun

  • 26

    Jun

  • 29

    Nov

KO

Coca-Cola

$45.55

-0.43 (-0.94%)

, PEP

PepsiCo

$117.15

-0.55 (-0.47%)

12:23
06/07/17
06/07
12:23
06/07/17
12:23
General news
On The Fly: Top stock stories at midday »

Stocks opened in positive…

KO

Coca-Cola

$45.55

-0.43 (-0.94%)

PEP

PepsiCo

$117.15

-0.55 (-0.47%)

DPS

Dr Pepper Snapple

$93.18

0.89 (0.96%)

KITE

Kite Pharma

$76.64

3.03 (4.12%)

NVS

Novartis

$81.22

-0.62 (-0.76%)

BLUE

bluebird bio

$98.20

6.9 (7.56%)

SAN

Banco Santander

$6.50

0.135 (2.12%)

PLAY

Dave & Buster's

$70.17

2.01 (2.95%)

CALA

Calithera Biosciences

$15.40

-0.15 (-0.96%)

DLTH

Duluth Holdings

$20.57

-0.06 (-0.29%)

AMBA

Ambarella

$59.72

0.77 (1.31%)

BPESY

Banco Popular

$1.61

-0.01 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 07

    Jun

  • 07

    Jun

  • 13

    Jun

  • 13

    Jun

  • 13

    Jun

  • 20

    Jun

  • 20

    Jun

  • 22

    Jun

  • 26

    Jun

  • 29

    Nov

CVNA

Carvana

, HA

Hawaiian Holdings

$52.85

0.25 (0.48%)

09:22
06/07/17
06/07
09:22
06/07/17
09:22
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Carvana (CVNA),…

CVNA

Carvana

HA

Hawaiian Holdings

$52.85

0.25 (0.48%)

CALA

Calithera Biosciences

$15.40

-0.15 (-0.96%)

DRWI

DragonWave

$0.65

-0.0198 (-2.98%)

DLTH

Duluth Holdings

$20.57

-0.06 (-0.29%)

AMBA

Ambarella

$59.72

0.77 (1.31%)

PLAY

Dave & Buster's

$70.17

2.01 (2.95%)

KMDA

Kamada

$8.20

-0.05 (-0.61%)

SHPG

Shire

$174.10

-1.75 (-1.00%)

EXAS

Exact Sciences

$36.59

-0.48 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

  • 07

    Jun

  • 07

    Jun

  • 13

    Jun

  • 13

    Jun

  • 13

    Jun

  • 20

    Jun

  • 26

    Jun

  • 29

    Aug

  • 07

    Jun

CALA

Calithera Biosciences

$15.40

-0.15 (-0.96%)

08:32
06/07/17
06/07
08:32
06/07/17
08:32
Technical Analysis
Technical View: Calithera Biosciences up, FDA Fast Track designation for CB-839 »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALA

Calithera Biosciences

$15.40

-0.15 (-0.96%)

06:46
06/07/17
06/07
06:46
06/07/17
06:46
Hot Stocks
Calithera Biosciences: FDA Fast Track designation granted to CB-839 »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CALA

Calithera Biosciences

$15.70

-0.4 (-2.48%)

06:48
06/05/17
06/05
06:48
06/05/17
06:48
Hot Stocks
Calithera Biosciences to present Phase I solid tumor data at ASCO »

Calithera Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

BMY

Bristol-Myers

$55.32

0.38 (0.69%)

, CALA

Calithera Biosciences

$11.30

0.4 (3.67%)

07:01
05/10/17
05/10
07:01
05/10/17
07:01
Hot Stocks
Bristol-Myers, Calithera Biosciences expand collaboration on Opdivo »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$55.32

0.38 (0.69%)

CALA

Calithera Biosciences

$11.30

0.4 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CALA

Calithera Biosciences

$11.30

0.4 (3.67%)

17:15
05/09/17
05/09
17:15
05/09/17
17:15
Hot Stocks
Calithera Biosciences sees cash, cash equivalents $180M-$190M year-end »

Calithera expects that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 02

    Jun

CALA

Calithera Biosciences

$11.30

0.4 (3.67%)

17:14
05/09/17
05/09
17:14
05/09/17
17:14
Earnings
Calithera Biosciences reports Q1 EPS (22c), consensus 14c »

Reports Q1 revenue $4.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 02

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.